Elite Pharmaceutical, Inc. (OTCBB:ELTP) announced today the launch of Lodrane D in cooperation with ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal (Hi-Tech). Product will be promoted/distributed in the U.S. by ECR and will be available over-the-counter. ELTP expects to receive revenues for the manufacturing, packaging, and laboratory stability study services for Lodrane D, […]